Correspondence on Editorial regarding "Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations".
作者信息
Lee Jun-Hyuk, Park Kyongmin, Lee Hye Sun, Park Hoon-Ki, Han Jee Hye, Ahn Sang Bong
机构信息
Department of Family Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
Department of Medicine, Graduate School of Hanyang University, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2023 Jan;29(1):185-187. doi: 10.3350/cmh.2022.0375. Epub 2022 Nov 10.
Abstract
摘要
相似文献
1
Correspondence on Editorial regarding "Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations".
Clin Mol Hepatol. 2023 Jan;29(1):185-187. doi: 10.3350/cmh.2022.0375. Epub 2022 Nov 10.
2
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations.
Clin Mol Hepatol. 2022 Oct;28(4):802-805. doi: 10.3350/cmh.2022.0249. Epub 2022 Sep 14.
3
The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults.
Clin Mol Hepatol. 2022 Oct;28(4):814-826. doi: 10.3350/cmh.2022.0099. Epub 2022 Jun 9.
4
The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
Diabetes Metab Syndr. 2015 Apr-Jun;9(2):114-9. doi: 10.1016/j.dsx.2013.10.008. Epub 2013 Nov 14.
5
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
6
Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study.
J Diabetes Complications. 2016 Mar;30(2):269-74. doi: 10.1016/j.jdiacomp.2015.11.019. Epub 2015 Dec 2.
7
Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.
Dis Markers. 2022 Feb 23;2022:4930355. doi: 10.1155/2022/4930355. eCollection 2022.
8
Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome.
Horm Metab Res. 2021 Feb;53(2):100-104. doi: 10.1055/a-1341-9710. Epub 2021 Jan 29.
9
Correspondence on Letter regarding "The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults".
Clin Mol Hepatol. 2023 Jan;29(1):179-181. doi: 10.3350/cmh.2022.0409. Epub 2022 Nov 22.
10
Prevalence of Nonalcoholic Fatty Liver Disease in Familial Mediterranean Fever.
Endocr Metab Immune Disord Drug Targets. 2020;20(6):952-958. doi: 10.2174/1871530320666200220125829.
本文引用的文献
1
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach.
Clin Mol Hepatol. 2022 Oct;28(4):841-850. doi: 10.3350/cmh.2022.0239. Epub 2022 Sep 19.
2
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations.
Clin Mol Hepatol. 2022 Oct;28(4):802-805. doi: 10.3350/cmh.2022.0249. Epub 2022 Sep 14.
3
Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Nutrients. 2022 Jul 24;14(15):3039. doi: 10.3390/nu14153039.
4
Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?
Clin Mol Hepatol. 2022 Jul;28(3):473-477. doi: 10.3350/cmh.2022.0155. Epub 2022 Jun 22.
5
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.
Clin Mol Hepatol. 2022 Jul;28(3):565-574. doi: 10.3350/cmh.2022.0096. Epub 2022 May 19.
6
Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.
Clin Mol Hepatol. 2022 Jul;28(3):510-521. doi: 10.3350/cmh.2021.0332. Epub 2022 Mar 17.
7
Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.
Dis Markers. 2022 Feb 23;2022:4930355. doi: 10.1155/2022/4930355. eCollection 2022.
8
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.
Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22.
9
Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance.
Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E186-E195. doi: 10.1152/ajpendo.00258.2018. Epub 2018 Dec 18.
10
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
Zotero 插件